JP2000516199A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516199A5
JP2000516199A5 JP1997532943A JP53294397A JP2000516199A5 JP 2000516199 A5 JP2000516199 A5 JP 2000516199A5 JP 1997532943 A JP1997532943 A JP 1997532943A JP 53294397 A JP53294397 A JP 53294397A JP 2000516199 A5 JP2000516199 A5 JP 2000516199A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997532943A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000516199A (ja
Filing date
Publication date
Priority claimed from FR9609400A external-priority patent/FR2751226B1/fr
Application filed filed Critical
Publication of JP2000516199A publication Critical patent/JP2000516199A/ja
Publication of JP2000516199A5 publication Critical patent/JP2000516199A5/ja
Pending legal-status Critical Current

Links

JP09532943A 1996-07-19 1997-07-15 ウマの予防用ポリヌクレオチドワクチン製剤 Pending JP2000516199A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9609400A FR2751226B1 (fr) 1996-07-19 1996-07-19 Formule de vaccin polynucleotidique contre les pathologies du cheval
FR96/09400 1996-07-19
PCT/FR1997/001314 WO1998003198A1 (fr) 1996-07-19 1997-07-15 Formule de vaccin polynucleotidique contre les pathologies du cheval

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007316669A Division JP2008143900A (ja) 1996-07-19 2007-12-07 ウマの予防用ポリヌクレオチドワクチン製剤

Publications (2)

Publication Number Publication Date
JP2000516199A JP2000516199A (ja) 2000-12-05
JP2000516199A5 true JP2000516199A5 (Direct) 2005-05-12

Family

ID=9494494

Family Applications (2)

Application Number Title Priority Date Filing Date
JP09532943A Pending JP2000516199A (ja) 1996-07-19 1997-07-15 ウマの予防用ポリヌクレオチドワクチン製剤
JP2007316669A Pending JP2008143900A (ja) 1996-07-19 2007-12-07 ウマの予防用ポリヌクレオチドワクチン製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007316669A Pending JP2008143900A (ja) 1996-07-19 2007-12-07 ウマの予防用ポリヌクレオチドワクチン製剤

Country Status (13)

Country Link
US (2) US6207166B1 (Direct)
EP (2) EP1647281A3 (Direct)
JP (2) JP2000516199A (Direct)
AR (2) AR009947A1 (Direct)
AU (1) AU735372B2 (Direct)
BR (1) BR9710502A (Direct)
CA (2) CA2660355C (Direct)
CZ (2) CZ301365B6 (Direct)
DE (1) DE69734778T2 (Direct)
FR (1) FR2751226B1 (Direct)
NZ (1) NZ333754A (Direct)
PL (1) PL188409B1 (Direct)
WO (1) WO1998003198A1 (Direct)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751226B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
NZ515993A (en) * 1999-06-10 2004-04-30 Merial Sas DNA vaccines for pets and sport animals
FR2794648B1 (fr) * 1999-06-10 2003-03-07 Merial Sas Vaccins adn pour animaux de compagnie et de sport
US6645740B1 (en) 1999-06-10 2003-11-11 Merial Limited Nucleic acids encodings equine GM-CSF
WO2001083528A2 (en) * 2000-05-01 2001-11-08 Powderject Vaccines, Inc. Nucleic acid immunization
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
FR2823222B1 (fr) 2001-04-06 2004-02-06 Merial Sas Vaccin contre le virus de la fievre du nil
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
EP2390352A1 (en) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systems and methods for improving protein and milk production of dairy herds
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
EP1689858B1 (en) 2003-11-13 2013-05-15 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
EP1718770B1 (en) 2004-02-19 2011-05-25 The Governors of the University of Alberta Leptin promoter polymorphisms and uses thereof
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
SI1881845T1 (sl) 2005-04-25 2010-06-30 Merial Ltd Cepiva proti virusu Nipah
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
EP3147296A1 (en) 2005-11-14 2017-03-29 Merial, Inc. Gene therapy for renal failure
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
US20080274137A1 (en) * 2007-05-02 2008-11-06 Jean Christophe Francis Audonnet DNA plasmids having improved expression and stability
HRP20130643T1 (hr) 2007-05-02 2013-08-31 Merial Limited Dnk-plazmidi koji imaju poboljšanu ekspresiju i stabilnost
EP3168307B1 (en) 2008-11-28 2020-07-15 Boehringer Ingelheim Animal Health USA Inc. Recombinant avian influenza vaccine and uses thereof
KR101715418B1 (ko) 2009-04-03 2017-03-10 메리얼 인코포레이티드 뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신
KR20120101572A (ko) 2009-12-28 2012-09-13 메리얼 리미티드 재조합 ｎｄｖ 항원 및 이의 용도
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
AU2011224188B2 (en) 2010-03-12 2015-01-22 Boehringer Ingelheim Animal Health USA Inc. Bluetongue virus recombinant vaccines and uses thereof
WO2012030720A1 (en) 2010-08-31 2012-03-08 Merial Limited Newcastle disease virus vectored herpesvirus vaccines
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
AU2012240240A1 (en) 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
AU2012240246A1 (en) 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
AU2012245395A1 (en) 2011-04-20 2013-11-14 Merial, Inc. Adjuvanted rabies vaccine with improved viscosity profile
AP2013007180A0 (en) 2011-04-25 2013-10-31 Advanced Bioscience Lab Inc Truncated HIV envelope proteins (ENV), methods andcompositions related thereto
MX361804B (es) 2011-05-27 2018-12-17 Boehringer Ingelheim Animal Health Usa Inc Vacunas genéticas contra el virus hendra y el virus nipah.
CA2837375C (en) 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
ES2626297T3 (es) 2011-08-12 2017-07-24 Merial, Inc. Preservación asistida por vacío de productos biológicos, en particular de vacunas
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
CN104203271B (zh) 2012-02-14 2017-08-25 梅里亚股份有限公司 表达狂犬病病毒和ox40蛋白的重组痘病毒载体及从其制造的疫苗
KR102087458B1 (ko) 2012-02-14 2020-03-10 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 로타바이러스 아단위 백신 및 그의 제조 방법 및 용도
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
KR101490292B1 (ko) 2012-04-16 2015-02-04 한국생명공학연구원 신규한 ｈ3ｎ8 말 인플루엔자 바이러스
CN104582724A (zh) 2012-06-13 2015-04-29 梅里亚有限公司 重配btv和ahsv疫苗
HK1216006A1 (zh) 2013-03-12 2016-10-07 Boehringer Ingelheim Animal Health USA Inc. 反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法
EP3215188A1 (en) 2014-11-03 2017-09-13 Merial, Inc. Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
NZ738957A (en) 2015-06-23 2019-09-27 Boehringer Ingelheim Animal Health Usa Inc Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
CA2996143A1 (en) 2015-08-20 2017-02-23 Merial, Inc. Fcv recombinant vaccines and uses thereof
RU2710854C1 (ru) 2015-09-29 2020-01-14 Мериал, Инк. Вакцины на основе вирусоподобных частиц (vlp) собачьего парвовируса (cpv) и их применение
ES2899230T3 (es) 2015-11-23 2022-03-10 Boehringer Ingelheim Animal Health Usa Inc Proteínas de fusión de FMDV y E2 y usos de las mismas
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
CN109136264B (zh) * 2018-09-19 2022-07-29 天康制药(苏州)有限公司 马疱疹病毒1型gB-gD融合蛋白、重组载体和真核细胞株及其制备方法和疫苗

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631191A (en) * 1985-06-20 1986-12-23 Biotechnology Research Partners, Ltd. Methods and compositions useful in preventing equine influenza
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
SU1671688A1 (ru) * 1989-01-27 1991-08-23 Всесоюзный Научно-Исследовательский Институт Молекулярной Биологии Штамм гибридных культивируемых клеток животных MUS мUSсULUS L. - продуцент моноклональных антител к гликопротеиду Е1 вируса восточного энцефаломиелита лошадей
US5185440A (en) * 1989-06-20 1993-02-09 North Carolina State University cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof
FR2659349B1 (fr) * 1990-03-12 1993-12-24 Rhone Merieux Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5243121A (en) 1992-03-19 1993-09-07 Engelhard Corporation Fluid catalytic cracking process for increased formation of isobutylene and isoamylenes
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
EP0740704A1 (en) * 1994-01-27 1996-11-06 University Of Massachusetts Medical Center Immunization by inoculation of dna transcription unit
FR2751226B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
US6565853B1 (en) * 1998-03-27 2003-05-20 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Recombinant virus

Similar Documents

Publication Publication Date Title
JP2000513396A5 (Direct)
JP2000502280A5 (Direct)
JP2000501771A5 (Direct)
JP2001506876A5 (Direct)
JP2001507081A5 (Direct)
JP2000506916A5 (Direct)
JP2000500076A5 (Direct)
JP2000515149A5 (Direct)
JP2001509136A5 (Direct)
JP2000500055A5 (Direct)
JP2000500026A5 (Direct)
JP2000502472A5 (Direct)
JP2000501825A5 (Direct)
JP2002514341A5 (Direct)
JP2000515997A5 (Direct)
JP2000516199A5 (Direct)
JP2000502425A5 (Direct)
JP2000502485A5 (Direct)
JP2001501584A5 (Direct)
JP2000502568A5 (Direct)
JP2000501774A5 (Direct)
JP2000502570A5 (Direct)
JP2000501876A5 (Direct)
JP2001504129A5 (Direct)
JP2000501744A5 (Direct)